1.Clinical features and genetic analysis of a case with Perlman syndrome due to variant of DIS3L2 gene.
Jing CHEN ; Chunhui HU ; Lanfen REN ; Jingjing LI ; Tao LEI ; Shuang CHEN ; Peiwei ZHAO
Chinese Journal of Medical Genetics 2022;39(1):48-51
OBJECTIVE:
To analyze the clinical phenotype and genetic characteristics of a child with Perlman syndrome.
METHODS:
Genomic DNA was extracted from peripheral blood samples from the patient and her parents. Whole exome sequencing (WES) was carried out to detect potential variant in the proband. Candidate variant was verified by Sanger sequencing. The pathogenicity of candidate variants was evaluated according to the guidelines of the American College of Medical Genetics and Genomics (ACMG).
RESULTS:
The results of WES showed that the proband has harbored compound heterozygous variants of the DIS3L2 gene, namely c.2109delC and c.1829.c.1830insC, which were respectively inherited from her mother and father. The results were confirmed by Sanger sequencing. Based on the ACMG guidelines, the two novel variants were both predicted to be pathogenic (PVS1+PS2+PM2).
CONCLUSION
The compound heterozygous variants of the DIS3L2 gene probably underlay the Perlman syndrome in this patient. Above finding has enriched the spectrum of DIS3L2 gene mutations.
Exoribonucleases
;
Female
;
Fetal Macrosomia
;
Genetic Testing
;
Genomics
;
Humans
;
Mutation
;
Whole Exome Sequencing
;
Wilms Tumor
2.Analyzed the molecular interaction network of tumor suppressor gene 14-3-3 sigma in lung cancer cell based on stable isotope labeling by amino acids in cell culture technology.
Ting XIAO ; Wei MI ; Min LI ; Bang-rong CAO ; Lin FENG ; Shu-jun CHENG ; Yan-ning GAO
Chinese Journal of Preventive Medicine 2013;47(8):752-756
OBJECTIVETo analysis the molecular interaction network of 14-3-3 sigma in non small cell lung cancer (NSCLC) cells.
METHODSEstablished stable over-expressed 14-3-3 sigma protein PG cells, MTT assay was used to assess the growth rate of PG cells. Though stable isotope labeling by amino acids in cell culture (SILAC) and Mass spectrometry (MS) technology, to identify difference expressed proteins caused by over expressed 14-3-3 sigma. The protein expressed >2 or <0.5 times was termed as the differential protein. By searching Human protein reference database (HPRD) and Kyoto encyclopedia of genes and genomes (KEGG), established the molecular interaction network of tumor suppressor gene 14-3-3 sigma.
RESULTSThe growth rate of over-expressed 14-3-3 sigma PG cell was obviously slower down compared to vector PG cells. A database including 147 differential protein was established. And a molecular interaction network of 14-3-3 sigma containing 26 protein was constructed.In this network, the expression of CSNK2A1 (casein kinase II subunit alpha), involved in numerous cellular processes, such as cell cycle progression, apoptosis and transcription, was the most significantly increased. A DNA repair protein, MEN1 (Menin) which functions as a transcriptional regulator was the most significantly decreased.
CONCLUSIONAfter stable transfected with 14-3-3 sigma gene, growth rate of PG cells was inhibited, the proteins associated with cell cycle, DNA damage repair mechanisms were significantly changed, and constructed the molecular interaction network.
14-3-3 Proteins ; genetics ; Amino Acids ; Biomarkers, Tumor ; genetics ; Carcinoma, Non-Small-Cell Lung ; genetics ; Cell Cycle ; Cell Line, Tumor ; Cell Proliferation ; Exoribonucleases ; genetics ; Humans ; Isotope Labeling ; methods ; Lung Neoplasms ; genetics ; Mass Spectrometry ; Transfection
3.Expression and clinical significance of 14-3-3 sigma and heat shock protein 27 in colorectal cancer.
Hai-ping PEI ; Hua GE ; Rui JIANG ; Hong ZHU
Chinese Journal of Gastrointestinal Surgery 2010;13(3):213-215
OBJECTIVETo investigate the expression of 14-3-3 sigma and heat shock protein 27 (HSP27) in colorectal carcinoma(CRC) tissue and its clinical significance.
METHODSThe expression of 14-3-3 sigma and HSP27 was detected by immunohistochemical staining in 50 pathologically verified CRC cases. The association of clinical data with 14-3-3 sigma and HSP27 expression was examined.
RESULTSThe positive expression rate of 14-3-3 sigma was 10% in normal control mucosa and 58% in CRC tissue (P<0.01). The positive expression rate of HSP27 was 16% in normal control mucosa and 54% in CRC tissue (P<0.01). No correlation between 14-3-3 sigma and HSP27 expression was found in CRC tissue (P>0.05). The expression of 14-3-3 sigma was associated with patient age, tumor diameter and lymph node metastasis (LNM) (P<0.05), but not with gender, tumor differentiation or serous membrane invasion (P>0.05). The expression of HSP27 was associated with LNM (P<0.05), but not with gender, age, differentiation, tumor diameter or serous membrane invasion (P>0.05).
CONCLUSIONThe abnormal expression of 14-3-3 sigma and HSP27 is significantly associated with LNM in CRC.
14-3-3 Proteins ; Adult ; Aged ; Biomarkers, Tumor ; metabolism ; Colorectal Neoplasms ; metabolism ; pathology ; Exonucleases ; metabolism ; Exoribonucleases ; Female ; HSP27 Heat-Shock Proteins ; metabolism ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Proteins ; metabolism ; Young Adult
4.Construction and expression of dendritic cell nucleic acid vaccine containing CML28 gene in human dendritic cells.
Dong-Hua ZHANG ; Hong-Sheng ZHOU ; Ya-Ya WANG ; Wen-Li LIU ; Zhen-Qian HUANG ; Huo TAN
Journal of Experimental Hematology 2005;13(4):631-636
This study was aimed to construct nucleic acid vaccine containing the coding region of the CML28 gene and to express it in human dendritic cells. The full length of CML28 cDNA was amplified from K562 by RT-PCR and subcloned into pGEM-T vector. The CML28 fragment was digested and subsequently inserted into the EcoRI-Xba I sites of pcDNA3.1HisA to construct the recombinant expression vector pcDNA3.1HisA-CML28, which was identified by restrition analysis and sequencing. Human dendritic cells (DC) were separated from peripheral blood mononuclear cells (PBMC) by culture with rhGM-CSF, rhIL-4 and assessed by flow cytometry. The constructed plasmid pcDNA3.1 HisA-CML28 was transfected into DC by electroporation. Western blot was used to detect the expression of fusion protein His-CML28. The results showed that recombinant plasmid pcDNA3.1HisA-CML28 contained the correct full CML28 cDNA identified by restriction analysis and sequencing, and can express the fusion protein His-CML28 in DCs. It is concluded that nucleic acid vaccine containing CML28 gene was constructed and expressed in DC successfully.
Antigens, Neoplasm
;
genetics
;
immunology
;
metabolism
;
Antigens, Surface
;
genetics
;
immunology
;
metabolism
;
Blotting, Western
;
Cells, Cultured
;
Cloning, Molecular
;
DNA, Complementary
;
genetics
;
Dendritic Cells
;
cytology
;
immunology
;
metabolism
;
Electrophoresis, Polyacrylamide Gel
;
Exoribonucleases
;
genetics
;
immunology
;
metabolism
;
Exosome Multienzyme Ribonuclease Complex
;
Flow Cytometry
;
Genetic Vectors
;
genetics
;
Humans
;
K562 Cells
;
RNA-Binding Proteins
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
;
Transfection
;
methods
;
Vaccines, DNA
;
biosynthesis
;
genetics
;
immunology
5.Monitoring CML28 mRNA levels in patients before and after HSCT by real-time quantitative RT-PCR.
Dong-Hua ZHANG ; Min DAI ; Hong-Sheng ZHOU ; Ya-Ya WANG ; Lu ZHANG ; Li ZHANG ; Bin WANG ; Wen-Jing CAO
Journal of Experimental Hematology 2005;13(5):843-847
The purpose of this study was to establish a SYBR Green I real-time quantitative RT-PCR method for investigating the correlation between CML28 mRNA expression levels and relapse of leukemia after allo-hematopoietic stem cell transplantation (HSCT). pcDNA3.1HisA-CML28 plasmid had been constructed as the standard template. Serial monitoring of CML28 mRNA levels by SYBR Green I real-time quantitative RT-PCR technique was performed in 14 patients, including 10 patients with CML and 3 patients with AML, 1 patient with Ph(+) ALL. The results showed that the sensitivity of the established method was at 10(-4) (0.05 ng) level, with interassay variation and intraassay variation of standard samples both below 10%. The CML28 was highly expressed in AML and CML-BP or AP. CML28 level in newly diagnosed group was (6.58 +/- 2.34) x 10(-2), in pre-conditioning regimen group was (2.19 +/- 0.32) x 10(-2), in group that 1 month after HSCT was (1.35 +/- 1.28) x 10(-2), in group that 3 months after HSCT was (4.57 +/- 6.39) x 10(-3). CML28 can be detected 3 months after HSCT in 1 patient with CML-CP and 3 patients with CML-AP or BC. 2 of them with low level (<2 x 10(-2)) survived without relapse, the other 2 case with high level (>2 x 10(-2)) relapsed within one year, 1 case died and 1 case received the second time HSCT, CML28 level decreased rapidly after HSCT, but still higher than 2 x 10(-2) and relapse has taken place. The conclusions was made that CML28 mRNA level is obviously correlated with the development of leukemia. Serial quantification of CML28 mRNA levels are necessary for HSCT recipients, and more informative than a single detection. Using of this assay to evaluate MRD in the patients received HSCT is helpful for prediction of relapse.
Adolescent
;
Adult
;
Antigens, Neoplasm
;
genetics
;
Antigens, Surface
;
genetics
;
Child
;
Exoribonucleases
;
genetics
;
Exosome Multienzyme Ribonuclease Complex
;
Female
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Leukemia
;
genetics
;
pathology
;
surgery
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local
;
Organic Chemicals
;
chemistry
;
RNA, Messenger
;
biosynthesis
;
genetics
;
RNA-Binding Proteins
;
Reverse Transcriptase Polymerase Chain Reaction
;
methods
;
Time Factors